Alzheimer's Research UK UCL Drug Discovery Institute

United Kingdom (UK)

1 July 2020 - 30 June 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Alzheimer's Research UK UCL Drug Discovery Institute published between 1 July 2020 - 30 June 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Alzheimer's Research UK UCL Drug Discovery Institute is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
2 0.17

Outputs by subject (Share)

Subject Count Share
Life Sciences 2 0.17

1 July 2020 - 30 June 2021

International vs. domestic collaboration by Share

  • 63.52% Domestic
  • 36.48% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 international collaborators by Share (14 total)

  • Alzheimer's Research UK UCL Drug Discovery Institute, United Kingdom (UK)
  • Foreign institution
  1. Max Planck Society, Germany (0.41)
    0.13
    0.28
  2. University of Helsinki, Finland (0.25)
    0.04
    0.21
  3. Helsinki University Central Hospital (HUCH), Finland (0.11)
    0.04
    0.07
  4. Karolinska Institute (KI), Sweden (0.11)
    0.04
    0.06
  5. Institut Cochin, France (0.10)
    0.04
    0.06
  6. Cancer Grand Challenges, United States of America (USA) (0.08)
    0.04
    0.03
  7. Harvard University, United States of America (USA) (0.08)
    0.04
    0.03
  8. The Hospital District of Helsinki and Uusimaa (HUS), Finland (0.08)
    0.04
    0.03
  9. Wihuri Research Institute (WRI), Finland (0.07)
    0.04
    0.03
  10. French National Centre for Scientific Research (CNRS), France (0.06)
    0.04
    0.02

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

Alzheimer's Research UK UCL Drug Discovery Institute is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs